共 50 条
- [22] Durvalumab for the treatment of PD-L1 non-small cell lung cancer EXPERT REVIEW OF PRECISION MEDICINE AND DRUG DEVELOPMENT, 2021, 6 (02): : 95 - 105
- [28] Expression of PD-L1 Is Associated with Inflammatory Microenvironment in Surgical Specimens of Non-Small Cell Lung Cancer JOURNAL OF PERSONALIZED MEDICINE, 2021, 11 (08):